Professor Dass majored in Medical Biotechnology, with a first class Honours from Charles Sturt University, NSW. He then obtained a doctorate in the field of Biomedical Sciences, in the area of cancer therapy, at the same University. Prof. Dass has 25 years of basic and applied research in cancer, with skills such as in vivo (small animal) and cell culture testing experience and significant drug formulation and delivery skills. His PhD project, on targeted gene therapy for cancer, in the mid-90s, was one of the earliest applications of gene transfer in Australia. He is well-versed in medium-throughput screening of potential lead compounds for cancer drug R&D, and he has worked on bigpharma projects (Amgen, Novartis, Glaxo-Wellcome, Johnson & Johnson) in oncology and drug testing. Prof. Dass also has 24 years of experience using a wide range of molecular techniques including real-time PCR, western blotting, immunohistochemistry and molecular therapy. Prof. Dass has been at a lab leadership role for the past 11 years, all in the area of cancer drug discovery, delivery and development.